Philip G. Ferstl

690 total citations
18 papers, 280 citations indexed

About

Philip G. Ferstl is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Philip G. Ferstl has authored 18 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Philip G. Ferstl's work include Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (7 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Philip G. Ferstl is often cited by papers focused on Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (7 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Philip G. Ferstl collaborates with scholars based in Germany, Spain and France. Philip G. Ferstl's co-authors include Jonel Trebicka, Stefan Zeuzem, Oliver Waidmann, Volkhard A. J. Kempf, Michael Hogardt, Natalie Filmann, Frank Erhard Uschner, Marcus M. Mücke, Andreas A. Schnitzbauer and Wen Gu and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Hepatology.

In The Last Decade

Philip G. Ferstl

16 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip G. Ferstl Germany 9 169 162 92 34 30 18 280
Alexander Queck Germany 9 275 1.6× 214 1.3× 91 1.0× 35 1.0× 15 0.5× 25 386
Dina Halegoua‐De Marzio United States 10 135 0.8× 110 0.7× 33 0.4× 53 1.6× 9 0.3× 28 288
Ester C. Little United States 9 228 1.3× 312 1.9× 164 1.8× 14 0.4× 21 0.7× 17 438
María Hernández‐Tejero Spain 8 439 2.6× 432 2.7× 130 1.4× 142 4.2× 25 0.8× 20 585
Alexander R. Bonnel United States 4 224 1.3× 231 1.4× 79 0.9× 29 0.9× 12 0.4× 5 332
Steve Lontos Australia 6 45 0.3× 52 0.3× 95 1.0× 45 1.3× 29 1.0× 9 270
L. Fanigliulo Italy 10 74 0.4× 83 0.5× 320 3.5× 13 0.4× 17 0.6× 15 497
Naina Shah United Kingdom 7 262 1.6× 311 1.9× 88 1.0× 109 3.2× 28 0.9× 10 444
Simone Novelli Italy 10 207 1.2× 218 1.3× 105 1.1× 86 2.5× 29 1.0× 25 392

Countries citing papers authored by Philip G. Ferstl

Since Specialization
Citations

This map shows the geographic impact of Philip G. Ferstl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip G. Ferstl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip G. Ferstl more than expected).

Fields of papers citing papers by Philip G. Ferstl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip G. Ferstl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip G. Ferstl. The network helps show where Philip G. Ferstl may publish in the future.

Co-authorship network of co-authors of Philip G. Ferstl

This figure shows the co-authorship network connecting the top 25 collaborators of Philip G. Ferstl. A scholar is included among the top collaborators of Philip G. Ferstl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip G. Ferstl. Philip G. Ferstl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Koschade, Sebastian E., Hubert Serve, Christian Brandts, et al.. (2023). Bone Marrow Assessment in Liver Cirrhosis Patients with Otherwise Unexplained Peripheral Blood Cytopenia. Journal of Clinical Medicine. 12(13). 4373–4373. 2 indexed citations
2.
Ferstl, Philip G., Natalie Filmann, Volkhard A. J. Kempf, et al.. (2023). Short Versus Long Antibiotic Therapy and Risk of Recurrence of Acute Cholangitis Due to Malignant Biliary Strictures. Journal of Clinical Medicine. 12(21). 6716–6716.
3.
Queck, Alexander, Wen Gu, Philip G. Ferstl, et al.. (2022). Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS. Hepatology. 77(2). 466–475. 14 indexed citations
4.
Ferstl, Philip G., Alexander Queck, Natalie Filmann, et al.. (2022). Comparison of short‐course antibiotic therapy of 6 or less days with a longer treatment in patients with cholangitis after liver transplantation. Transplant Infectious Disease. 24(4). e13868–e13868. 4 indexed citations
5.
Ferstl, Philip G. & Jonel Trebicka. (2021). Acute Decompensation and Acute-on-Chronic Liver Failure. Clinics in Liver Disease. 25(2). 419–430. 29 indexed citations
6.
Ferstl, Philip G., Martin Schulz, & Jonel Trebicka. (2021). Akute Dekompensation und akut-auf-chronisches Leberversagen. Der Gastroenterologe. 16(3). 179–185.
7.
Uschner, Frank Erhard, Martin Schulz, Olaf Tyc, et al.. (2021). SAFETY AND PRELIMINARY EFFICACY AND PHARMACOKINETICS OF INTRAPERITONEAL VS-01 INFUSIONS IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A FIRST-IN-HUMAN, OPEN-LABEL, PHASE 1b CLINICAL TRIAL. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations
8.
Queck, Alexander, Frank Erhard Uschner, Philip G. Ferstl, et al.. (2021). Role of circulating angiogenin levels in portal hypertension and TIPS. PLoS ONE. 16(8). e0256473–e0256473. 3 indexed citations
9.
Ferstl, Philip G., Natalie Filmann, Andreas A. Schnitzbauer, et al.. (2021). Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates. PLoS ONE. 16(1). e0245091–e0245091. 32 indexed citations
10.
Gu, Wen, Hans‐Peter Erasmus, Frank Erhard Uschner, et al.. (2021). Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). The Lancet Regional Health - Europe. 12. 100240–100240. 76 indexed citations
11.
Schultze, Tilman, Philip G. Ferstl, Michael Hogardt, et al.. (2021). Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates. Frontiers in Microbiology. 12. 791574–791574. 4 indexed citations
12.
Mücke, Marcus M., Victoria T. Mücke, Christiana Graf, et al.. (2020). Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis. Clinical and Translational Gastroenterology. 11(8). e00223–e00223. 29 indexed citations
13.
Mücke, Marcus M., Victoria T. Mücke, Christiana Graf, et al.. (2020). Reduced efficacy of norfloxacin prophylaxis to prevent spontaneous bacterial peritonitis over time: a systematic review and meta-analysis. Journal of Hepatology. 73. S741–S742. 1 indexed citations
14.
Ferstl, Philip G., Natalie Filmann, Michael Hogardt, et al.. (2018). Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms. Infection and Drug Resistance. Volume 11. 2047–2061. 10 indexed citations
15.
Walter, Dirk, Philip G. Ferstl, Oliver Waidmann, et al.. (2018). Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification. Liver International. 39(2). 316–323. 27 indexed citations
16.
Ferstl, Philip G., Claudia Reinheimer, Stefan Zeuzem, et al.. (2017). Severe infection with multidrug-resistantSalmonella choleraesuisin a young patient with primary sclerosing cholangitis. World Journal of Gastroenterology. 23(11). 2086–2086. 4 indexed citations
17.
Ferstl, Philip G., Natalie Filmann, Christian Brandt, et al.. (2017). The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease. Liver International. 37(10). 1488–1496. 15 indexed citations
18.
Rittweger, Jörn, Tadej Debevec, Petra Frings‐Meuthen, et al.. (2016). On the combined effects of normobaric hypoxia and bed rest upon bone and mineral metabolism: Results from the PlanHab study. Bone. 91. 130–138. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Queck Breakdown of academic impact, for papers by Dina Halegoua‐De Marzio Breakdown of academic impact, for papers by Ester C. Little Breakdown of academic impact, for papers by María Hernández‐Tejero Breakdown of academic impact, for papers by Alexander R. Bonnel Breakdown of academic impact, for papers by Steve Lontos Breakdown of academic impact, for papers by L. Fanigliulo Breakdown of academic impact, for papers by Naina Shah Breakdown of academic impact, for papers by Simone Novelli
Rankless by CCL
2026